Evidence map›Paper›PMID 38992708›Full record

ArticleAntimicrobial resistance and infection control2024

Staphylococcus aureus screening and preoperative decolonisation with Mupirocin and Chlorhexidine to reduce the risk of surgical site infections in orthopaedic surgery: a pre-post study.

Antoine Portais, Meghann Gallouche, Patricia Pavese, Yvan Caspar, Jean-Luc Bosson, Pascal Astagneau, Regis Pailhé, Jérôme Tonetti, Brice Rubens Duval, Caroline Landelle

Abstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Antoine Portais *Infectious and Tropical Diseases Unit, Grenoble Alpes University Hospital, Grenoble, France.
Meghann Gallouche *Hospital Hygiene Unit, Grenoble Alpes University Hospital, Grenoble, France. mgallouche@chu-grenoble.fr.
Patricia PaveseInfectious and Tropical Diseases Unit, Grenoble Alpes University Hospital, Grenoble, France.
Yvan CasparBacteriology Laboratory, Grenoble Alpes University Hospital, Grenoble, France.
Jean-Luc BossonUniv. Grenoble Alpes, CNRS, Grenoble INP, TIMC, Grenoble, France.
Pascal AstagneauCentre for the prevention of healthcare associated infections (CPIAS), Paris, France.
Regis PailhéOrthopaedic Surgery Unit, Clinique Aguiléra, Ramsay Santé, Biarritz, France.
Jérôme TonettiDepartment of Orthopaedic Surgery, Grenoble Alpes University Hospital, Grenoble, France.
Brice Rubens DuvalDepartment of Osteoarthritis and Sport Surgery, Grenoble Alpes University Hospital, Grenoble, France.
Caroline LandelleHospital Hygiene Unit, Grenoble Alpes University Hospital, Grenoble, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNasal carriage of Staphylococcus aureus is a risk factor for surgical site infections (SSI) in orthopaedic surgery. The efficacy of decolonisation for S. aureus on reducing the risk of SSI is uncertain in this speciality. The objective was to evaluate the impact of a nasal screening strategy of S. aureus and targeted decolonisation on the risk of S. aureus SSI.

methodsA retrospective pre-post and here-elsewhere study was conducted between January 2014 and June 2020 in 2 adult orthopaedic surgical sites (North and South) of a French university hospital. Decolonisation with Mupirocin and Chlorhexidine was conducted in S. aureus carriers starting February 2017 in the South site (intervention group). Scheduled surgical procedures for hip, knee arthroplasties, and osteosyntheses were included and monitored for one year. The rates of S. aureus SSI in the intervention group were compared to a historical control group (South site) and a North control group. The risk factors for S. aureus SSI were analysed by logistic regression.

resultsA total of 5,348 surgical procedures was included, 100 SSI of which 30 monomicrobial S. aureus SSI were identified. The preoperative screening result was available for 60% (1,382/2,305) of the intervention group patients. Among these screenings, 25.3% (349/1,382) were positive for S. aureus and the efficacy of the decolonisation was 91.6% (98/107). The rate of S. aureus SSI in the intervention group (0.3%, 7/2,305) was not significantly different from the historical control group (0.5%, 9/1926) but differed significantly from the North control group (1.3%, 14/1,117). After adjustment, the risk factors of S. aureus SSI occurrence were the body mass index (ORa

conclusionsDespite the low number of SSI, nasal screening and targeted decolonisation of S. aureus were associated with a reduction in S. aureus SSI.

Indexed as

Anti-Bacterial AgentsChlorhexidineMupirocinOrthopedic ProceduresStaphylococcal InfectionsStaphylococcus aureusSurgical Wound InfectionAgedCarrier StateFemaleFranceHumansMaleMass ScreeningMiddle AgedPreoperative CareAnti-Bacterial AgentsChlorhexidineMupirocinChlorhexidineDecolonisationMupirocinScreeningStaphylococcus aureusSurgical site infection

Identifiers

PMID38992708
PMCPMC11238515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.